| NCT02972918 | Ventricular Dysfunction, Left|Hip Fracture | Drug: Levosimendan | Hospital Universitario de Canarias|Orion Corporation, Orion Pharma | | 2014-05-01 | 2016-11-21 |
| NCT01969071 | Mitral Valve Stenosis With Incompetence or Regurgitation | Drug: Levosimendan|Drug: Dobutamine | Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital | Phase 4 | 2009-07-01 | 2013-10-23 |
| NCT01120106 | Low Cardiac Output Syndrome | Drug: levosimendan|Drug: placebo | Bambino Ges霉 Hospital and Research Institute | Phase 2 | 2009-01-01 | 2012-06-22 |
| NCT00988806 | Advanced Heart Failure | Drug: Levosimendan|Drug: Placebo | Hospital Universitario de Canarias | Phase 4 | 2009-11-01 | 2013-09-17 |
| NCT01318460 | Coronary Artery Disease | Drug: Levosimendan infusion|Drug: Placebo infusion | AHEPA University Hospital|Orion Corporation, Orion Pharma | Phase 4 | 2011-03-01 | 2014-03-11 |
| NCT03022877 | Myocardial Infarction|Outcome | Drug: Levosimendan | RWTH Aachen University | | 2017-06-01 | 2017-01-12 |
| NCT01720030 | Acute Kidney Injury | Drug: Levosimendan|Drug: Conventional therapy | VieCuri Medical Centre|Orion Corporation, Orion Pharma | Phase 2|Phase 3 | 2016-09-01 | 2016-09-26 |
| NCT01065194 | Chronic Stable Heart Failure | Drug: Levosimendan|Drug: Placebo | Medical University Innsbruck|Orion Corporation, Orion Pharma | Phase 3 | 2009-08-01 | 2010-08-27 |
| NCT02531724 | Acute Kidney Injury|Renal Insufficiency, Acute | Drug: Levosimendan|Drug: Placebo | Sahlgrenska University Hospital, Sweden | Phase 4 | 2015-09-01 | 2016-06-15 |
| NCT01536132 | Heart Failure | Drug: Levosimendan|Drug: Placebo | Parc de Salut Mar | Phase 4 | 2010-04-01 | 2016-02-13 |
| NCT01221116 | Heart Failure|Cardiac Surgery | Drug: levosimendan | Ullevaal University Hospital | | 2003-01-01 | 2010-11-01 |
| NCT01721434 | Muscle Weakness Conditions|Weaning Failure | Drug: Levosimendan|Drug: Placebo | University Medical Center Nijmegen|Orion Corporation, Orion Pharma | Phase 2|Phase 3 | 2012-09-01 | 2015-06-09 |
| NCT01290146 | Advanced Chronic Heart Failure | Drug: Diuretics|Drug: Levosimendan | Niguarda Hospital|Orion Corporation, Orion Pharma | Phase 3 | 2011-02-01 | 2016-01-16 |
| NCT01210976 | Heart Valve Disease | Drug: levosimendan|Drug: placebo | Tampere University Hospital | Phase 4 | 2009-01-01 | 2011-09-20 |
| NCT00154115 | Heart Failure | Drug: levosimendan|Drug: placebo | Kuopio University Hospital | Phase 4 | 2005-03-01 | 2009-01-20 |
| NCT02640846 | Septic Shock|Cardiomyopathy | Drug: Levosimendan|Drug: Milrinone | Sahlgrenska University Hospital, Sweden | Phase 4 | 2015-12-01 | 2016-02-02 |
| NCT01301313 | Acute Heart Failure | Drug: Levosimendan|Drug: Conventional intensified inotropic treatment | Jose Luis Vazquez Martinez|Hospital Universitario Ramon y Cajal | Phase 2 | 2011-02-01 | 2013-01-30 |
| NCT02133105 | Cardiorenal Syndrome | Drug: Levosimendan|Drug: Dobutamine | G枚teborg University|Sahlgrenska University Hospital, Sweden | Phase 3 | 2014-04-01 | 2017-02-01 |
| NCT00994825 | Low Cardiac Output Syndrome | Drug: Levosimendan|Drug: placebo | Universit脿 Vita-Salute San Raffaele | Phase 4 | 2009-11-01 | 2016-07-21 |
| NCT02025621 | Coronary Artery Bypass Grafting|Mitral Valve Surgery|Low Cardiac Output Syndrome | Drug: Levosimendan|Drug: Placebo | Tenax Therapeutics, Inc. | Phase 3 | 2014-07-01 | 2016-11-18 |
